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BACKGROUND
● G0S2 is a direct retinoic acid target gene implicated in 
the regulation of diverse biological processes.
● G0S2 has been defined as a novel tumor suppressor 
opposing oncogenic transformation by repressing 
MYC activity and mTOR signalling.
● G0S2 is involved in the control of lipolysis.  It inhibits 
the activity of adipose triglyceride lipase (ATGL) which 
is the first enzyme in a series of three to break down 
lipid droplets
● G0S2 knockout female mice have a lactation defect
ABSTRACT
G0/G1 switch gene 2 (G0S2) is a direct retinoic acid target gene widely 
expressed in diverse organs and implicated in cancer based on frequent 
methylation-mediated silencing in diverse solid tumors. We have previously 
shown G0S2 to be a novel breast cancer tumor suppressor. In addition, there is 
some evidence that G0S2 is highly expressed in normal breast epithelial tissue 
and may become downregulated by immortalization and transformation. We 
found that G0S2 is highly expressed in the mammary gland ductal branching of 
mice. Further, G0S2 knockout mice have a lactation defect. However, its not yet 
clear whether G0S2 is involved in breast cancer initiation and progression. We 
hypothesize that G0S2 plays a role in normal breast epithelial cell differentiation 
and that loss of G0S2 may result in aberrant differentiation leading to a more 
cancer prone state. Our results show that G0S2 expression is increased during 
lactogenic induced differentiation in immortalized mouse epithelial cells. We 
have also observed that not all mouse breast cancer cell lines have a decrease 
in G0S2 expression compared to normal mouse mammary derived cell lines.  
For future studies, we will further elucidate the role of G0S2 in breast epithelial 
differentiation and cancer. This will aid in the development of future breast 
cancer therapies. 
AIM
To establish the role of G0S2 in breast epithelial differentiation and 
cancer using an in vitro model in mouse breast epithelial cells
• Question 1: Does G0S2 expression increase with lactogenic 
differentiation in immortalized mouse breast epithelial cells?
• Question 2: Is G0S2 overexpressed in mouse normal breast 
epithelial cells in comparison to mouse breast cancer cells?
RESULTS
➢ Lactogenic induced hormonal differentiation of HC11
➢G0S2 expression increases with lactation in HC11
➢Not all mouse breast cancer cell line show a decrease 
in G0S2 transcript
Cell Type
HC11: Mouse Epithelium, Immortalized & non-transformed
Eph4-EV: An immortalized mouse mammary epithelia cell line
4T1: Mouse mammary tumor cells of a stage IV human breast cancer
MET1: Mouse mammary tumor cell line derived from malignant neoplasms of the mouse 
mammary gland
E0771: Medullary breast cancer adenocarcinoma cell line originally isolated as a 
spontaneous tumor from C57BL/6 mouse
CONCLUSION
● Increased milk protein gene expression confirms 
induction of lactogenic differentiation in HC11 cells
● Lactogenic induced differentiation in HC11 cells leads to 
an increase in G0S2 expression
● Comparison of G0S2 expression levels between 
immortalized normal mouse mammary epithelial cells 
and tumorigenic mouse mammary epithelial cells did not 
show the anticipated decrease of G0S2 in the tumor cell 
lines
FUTURE DIRECTIONS
● Determine which estrogen receptors are expressed by 
each of the three cancer cell lines used
● Test whether G0S2 expression is altered in a time-
dependent manner during induced differentiation of 
HC11 cells
● Generate HC11 cells with a stable overexpression or a 
stable knockdown of G0S2 to test whether G0S2 plays a 
causal role in HC11 cell differentiation
● Assess if G0S2 knockdown and overexpression alters 
the proliferative and other pro-cancer properties of 
HC11 cells including the susceptibility of the cells to be 
transformed with oncogenes
● Establish the in vivo role of G0S2 in xenograft and 
transgenic mouse models of breast cancer
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MATERIALS & METHODS
Cell culture. Cells were cultured either in DMEM or RPMI 
media with 10% fetal bovine serum supplemented with 
glutamine and antibiotics.
Cell Differentiation. Cells were plated at 100,000 cells per 
well in 6 well plates. The lactogenic hormones 
dexamethasone, insulin, and prolactin were added to the 
cells every 2 days for 8 days to induce lactation in HC11 
cells. 
RNA extraction. RNA was extracted from cultured cells 
using purelink RNA Isolation Kit - Thermo Fisher Scientific
cDNA synthesis. cDNA was made using the High-Capacity 
cDNA Reverse Transcription Kit - Thermo Fisher Scientific
Real-time PCR. cDNA with SYBR green was used for real-
time PCR and data was analyzed using the ddCT method 
normalized to GAPDH. 
BACKGROUND
● Recent observation in lab shows elevated G0s2 
expression in the mammary gland ductal branching. 
● G0S2 expression peaks at lactation
The image above displays relative expression levels of mouse G0s2 in
puberty, pregnancy, lactation, and involution. Data is from
microarray analysis of RNA samples from GEO profiles
(https://www.ncbi.nlm.nih.gov/geo/tools/profileGraph.cgi?ID=GDS
2360:97531_at)
Carmine Stain for whole mount mouse mammary 
gland
Lacz Stain for whole mount mouse mammary gland
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